• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Failure of estrogen plus progestin therapy for prevention.

作者信息

Fletcher Suzanne W, Colditz Graham A

出版信息

JAMA. 2002 Jul 17;288(3):366-8. doi: 10.1001/jama.288.3.366.

DOI:10.1001/jama.288.3.366
PMID:12117403
Abstract
摘要

相似文献

1
Failure of estrogen plus progestin therapy for prevention.雌激素加孕激素预防治疗失败。
JAMA. 2002 Jul 17;288(3):366-8. doi: 10.1001/jama.288.3.366.
2
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.健康绝经后妇女使用雌激素加孕激素的风险与益处：妇女健康倡议随机对照试验的主要结果
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
3
[Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study].[绝经后女性激素替代疗法的风险与益处。妇女健康倡议研究]
Internist (Berl). 2003 Jul;44(7):896-8. doi: 10.1007/s00108-003-0985-6.
4
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.雌激素加孕激素用于绝经后妇女冠心病二级预防的随机试验。心脏与雌激素/孕激素替代研究（HERS）研究组
JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605.
5
What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
Am J Health Syst Pharm. 2003 Feb 1;60(3):281-4. doi: 10.1093/ajhp/60.3.281.
6
Estrogen plus progestin and the risk of coronary heart disease.雌激素加孕激素与冠心病风险
N Engl J Med. 2003 Aug 7;349(6):523-34. doi: 10.1056/NEJMoa030808.
7
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.雌激素加孕激素对健康绝经后妇女乳腺癌及乳腺钼靶检查的影响：妇女健康倡议随机试验
JAMA. 2003 Jun 25;289(24):3243-53. doi: 10.1001/jama.289.24.3243.
8
Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits".关于“绝经后女性的绝经激素治疗：风险与益处”的评论
South Med J. 2014 Nov;107(11):696-7. doi: 10.14423/SMJ.0000000000000191.
9
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.雌激素加孕激素对绝经后女性整体认知功能的影响：女性健康倡议记忆研究：一项随机对照试验。
JAMA. 2003 May 28;289(20):2663-72. doi: 10.1001/jama.289.20.2663.
10
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.雌激素加孕激素与绝经后女性痴呆症和轻度认知障碍的发生率：女性健康倡议记忆研究：一项随机对照试验
JAMA. 2003 May 28;289(20):2651-62. doi: 10.1001/jama.289.20.2651.

引用本文的文献

1
The impact of 17β-estradiol on the estrogen-deficient female brain: from mechanisms to therapy with hot flushes as target symptoms.17β-雌二醇对雌激素缺乏女性大脑的影响：以热潮红为靶症状的从机制到治疗。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1310432. doi: 10.3389/fendo.2023.1310432. eCollection 2023.
2
Hormones and thrombosis: the dark side of the moon.激素与血栓形成：月亮的阴暗面。
Blood Transfus. 2024 Jan;22(1):46-54. doi: 10.2450/BloodTransfus.535. Epub 2023 Apr 27.
3
Epidemiology and Risk Factors for Breast Cancer: 21st Century Advances, Gaps to Address through Interdisciplinary Science.
乳腺癌的流行病学和危险因素：21 世纪的进展，通过跨学科科学解决差距。
Cold Spring Harb Perspect Med. 2023 Sep 1;13(9):a041317. doi: 10.1101/cshperspect.a041317.
4
Sex Difference in OA: Should We Blame Estrogen?骨关节炎中的性别差异：我们该归咎于雌激素吗？
Eur J Rheumatol. 2023 Jan 23;11(Suppl 1):S7-S14. doi: 10.5152/eurjrheum.2023.20193.
5
Ceritinib (LDK378) prevents bone loss suppressing Akt and NF-κB-induced osteoclast formation.塞瑞替尼（LDK378）可预防骨质流失，抑制 Akt 和 NF-κB 诱导的破骨细胞形成。
Front Endocrinol (Lausanne). 2022 Nov 8;13:939959. doi: 10.3389/fendo.2022.939959. eCollection 2022.
6
Estrogen therapy for osteoporosis in the modern era.现代医学中的雌激素治疗骨质疏松症。
Osteoporos Int. 2018 May;29(5):1049-1055. doi: 10.1007/s00198-018-4414-z. Epub 2018 Mar 8.
7
Effect of hormone replacement therapy on cardiac autonomic modulation.激素替代疗法对心脏自主神经调节的影响。
Clin Auton Res. 2014 Apr;24(2):63-70. doi: 10.1007/s10286-014-0226-1. Epub 2014 Feb 12.
8
Osteoporosis medication adherence: physician perceptions vs. patients' utilization.骨质疏松症药物治疗依从性：医生认知与患者利用的对比。
Bone. 2013 Jul;55(1):1-6. doi: 10.1016/j.bone.2013.03.003. Epub 2013 Mar 15.
9
Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.医生在治疗绝经后骨质疏松症方面的差异：来自 POSSIBLE US™ 治疗登记研究的结果。
Drugs Aging. 2011 Sep 1;28(9):713-27. doi: 10.2165/11595190-000000000-00000.
10
New evidence rekindles the hormone therapy debate.新证据重新引发了激素疗法的争论。
J Fam Plann Reprod Health Care. 2010 Apr;36(2):61-4. doi: 10.1783/147118910791069277.